Brandinium

Trademark search for:

AMYLIN

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2004-11-09 — Application filed
  • 2004-11-15 — Application filed
  • 2005-06-14 — Assigned to examiner
  • 2005-06-15 — Final disposition recorded
  • 2005-06-15 — Final disposition recorded
  • 2005-11-26 — Teas change of correspondence received
  • 2005-12-13 — Office action issued
  • 2005-12-13 — Correspondence received in law office
  • 2005-12-23 — Teas/email correspondence entered
  • 2006-01-10 — Final disposition recorded
  • 2006-01-10 — Final disposition recorded
  • 2006-07-10 — Office action issued
  • 2006-07-10 — Correspondence received in law office
  • 2006-07-27 — Teas/email correspondence entered
  • 2006-08-08 — Final disposition recorded
  • 2006-08-08 — Final disposition recorded
  • 2006-11-06 — Teas amendment of use received
  • 2006-11-06 — Use amendment filed
  • 2006-11-14 — Teas change of correspondence received
  • 2006-11-29 — Amendment to use processing complete
  • 2006-11-29 — Use amendment accepted
  • 2006-11-29 — Report unresponsive amendment - completed
  • 2006-11-29 — Assigned to lie
  • 2007-02-08 — Fax received
  • 2007-02-08 — Correspondence received in law office
  • 2007-02-10 — Amendment from applicant entered
  • 2007-03-05 — Final disposition recorded
  • 2007-03-05 — Final disposition recorded
  • 2007-08-30 — Attorney/dom.rep.revoked and/or appointed
  • 2007-08-30 — Teas revoke/app/change addr of atty/dom rep received
  • 2007-09-06 — Paper received
  • 2007-09-07 — Amendment from applicant entered
  • 2007-09-07 — Correspondence received in law office
  • 2007-09-19 — Application abandoned
  • 2007-09-25 — Application abandoned
  • 2007-09-26 — Approved for pub - principal register
  • 2007-09-28 — Law office publication review completed
  • 2007-10-15 — Office action issued
  • 2007-10-17 — Notice of publication
  • 2007-11-06 — Published for opposition
  • 2008-01-22 — Registered-principal register
  • 2010-10-19 — Attorney/dom.rep.revoked and/or appointed
  • 2010-10-19 — Teas revoke/app/change addr of atty/dom rep received
  • 2012-10-31 — Automatic update of assignment of ownership
  • 2013-03-05 — Teas section 8 & 15 received
  • 2013-03-19 — Case assigned to post registration paralegal
  • 2013-03-20 — Registered - sec. 8 (6-yr) accepted & sec. 15 ack.
  • 2013-03-20 — Notice of acceptance of sec. 8 & 15 - e-mailed
  • 2013-05-29 — Attorney/dom.rep.revoked and/or appointed
  • 2013-05-29 — Teas revoke/app/change addr of atty/dom rep received
  • 2014-03-24 — Attorney/dom.rep.revoked and/or appointed
  • 2014-03-24 — Teas revoke/app/change addr of atty/dom rep received
  • 2017-01-22 — Courtesy reminder - sec. 8 (10-yr)/sec. 9 e-mailed
  • 2018-08-24 — Cancelled sec. 8 (10-yr)/expired section 9
  • 2018-08-24 — Final status recorded

Owner Information

AMYLIN PHARMACEUTICALS, LLC
SAN DIEGO , CA
Amylin Pharmaceuticals, Inc.
San Diego , CA
Amylin Pharmaceuticals, Inc.
San Diego , CA
Amylin Pharmaceuticals, Inc.
San Diego , CA

Correspondent

Marc Stanislawczyk AstraZeneca Pharmaceuticals LP
1800 Concord Pike
FOP3-022
Wilmington, DE 19850-5437

Filing Details

Filing Date:
2004-11-09
Status Date:
2018-08-24
Category:
Electronics & Software
Filing Year:
2004

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.